DR. AARON I VINIK, MD
Osteopathic Medicine at Brambleton Ave, Norfolk, VA
License number
Virginia 0101046182
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
855 W Brambleton Ave, Norfolk, VA 23510
Phone
(757) 446-5908
(757) 446-7055 (Fax)
(757) 446-7055 (Fax)
Professional information
Dr. Aaron I Vinik - MD (Doctor of Medicine)
Hospitals:
EVMS Strelitz Diabetes Center
855 W Brambleton Ave, Norfolk 23510
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
EVMS Strelitz Diabetes Center
855 W Brambleton Ave, Norfolk 23510
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
855 W Brambleton Ave, Norfolk 23510
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
EVMS Strelitz Diabetes Center
855 W Brambleton Ave, Norfolk 23510
Sentara Norfolk General Hospital
600 Gresham Dr, Norfolk 23507
Education:
Medical Schools
University of The Witwatersrand/Faculty of Health Sciences
University of The Witwatersrand/Faculty of Health Sciences
Nutraceuticals For The Treatment Of Neuropathy
US Patent:
2006027, Nov 30, 2006
Filed:
May 11, 2006
Appl. No.:
11/431830
Inventors:
Aaron Vinik - Norfolk VA, US
Jorge Jacot - Virginia Beach VA, US
Jorge Jacot - Virginia Beach VA, US
Assignee:
Eastern Virginia Medical School - Norfolk VA
International Classification:
A61K 31/714, A61K 31/375, A61K 31/4415, A61K 31/455, A61K 31/525, A61K 31/51, A61K 31/385, A61K 31/355, A61K 31/22
US Classification:
514052000, 514251000, 514547000, 514440000, 514276000, 514350000, 514356000, 514458000, 514474000
Abstract:
The invention describes a novel combination of neutraceuticals. The invention also provides novel kits comprising a novel combination of neutraceuticals. The invention also provides methods for treating symptoms or delaying the progression of neuropathy, e.g., diabetic neuropathy, ischemic neuropathy, metabolic neuropathy, neuropathy due to aging, HIV neuropathy, chemotherapeutic-induced neuropathy, para-neoplastic neuropathy, metabolic neuropathy, and the like.
Ingap Protein Involved In Pancreatic Islet Neogenesis
US Patent:
5840531, Nov 24, 1998
Filed:
Sep 9, 1996
Appl. No.:
8/709662
Inventors:
Aaron I. Vinik - Norfolk VA
Gary L. Pittenger - Virgina Beach VA
Ronit Rafaeloff - Chesapeake VA
Lawrence Rosenberg - Montreal, CA
William P. Duguid - Montreal, CA
Gary L. Pittenger - Virgina Beach VA
Ronit Rafaeloff - Chesapeake VA
Lawrence Rosenberg - Montreal, CA
William P. Duguid - Montreal, CA
Assignee:
MoGill University
Eastern Virginia Medical School of the Medicine College of Hampton Roads - Norfolk VA
Eastern Virginia Medical School of the Medicine College of Hampton Roads - Norfolk VA
International Classification:
C12N 1500
US Classification:
435 691
Abstract:
Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display technique a cDNA clone expressed in cellophane wrapped but not in control pancreata was identified. Using this cDNA as a probe, a cDNA library was screened and a gene not previously described was identified and named INGAP.
Composition And Method For Treating Diabetes
US Patent:
2004013, Jul 8, 2004
Filed:
Sep 24, 2002
Appl. No.:
10/253733
Inventors:
Aaron Vinik - Norfolk VA, US
Lawrence Rosenberg - Montreal, CA
Gary Pittenger - Virginia Beach VA, US
David Taylor-Fishwick - Norfolk VA, US
Michael Salem - Ft. Lauderdale FL, US
Scott Mohrland - Plantation FL, US
Lawrence Rosenberg - Montreal, CA
Gary Pittenger - Virginia Beach VA, US
David Taylor-Fishwick - Norfolk VA, US
Michael Salem - Ft. Lauderdale FL, US
Scott Mohrland - Plantation FL, US
Assignee:
The Procter & Gamble Company
International Classification:
A61K038/17
US Classification:
514/012000, 514/013000, 514/014000
Abstract:
The present invention comprises dosing regimens and formulations of islet cell neogenesis associated protein (INGAP) and INGAP Peptide. The formulation disclosed herein is shown have acceptable stability as a pharmaceutical composition. Further, the formulation is able to regenerate functional islets.
Ingap Protein Involved In Pancreatic Islet Neogenesis
US Patent:
5834590, Nov 10, 1998
Filed:
Feb 22, 1995
Appl. No.:
8/401530
Inventors:
Aaron I. Vinik - Norfolk VA
Gary L. Pittenger - Virginia Beach VA
Ronit Rafaeloff - Norfolk VA
Lawrence Rosenberg - Montreal, CA
William P. Duguid - Montreal, CA
Gary L. Pittenger - Virginia Beach VA
Ronit Rafaeloff - Norfolk VA
Lawrence Rosenberg - Montreal, CA
William P. Duguid - Montreal, CA
Assignee:
Eastern Virginia Medical School of the Medical College of Hampton Roads - Norfolk VA
International Classification:
C07K 1400
US Classification:
530350
Abstract:
Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display technique a cDNA clone expressed in cellophane wrapped but not in control pancreata was identified. Using this cDNA as a probe, a cDNA library was screened and a gene not previously described was identified and named INGAP.
Ingap Protein Involved In Pancreatic Islet Neogenesis
US Patent:
RE39062, Apr 11, 2006
Filed:
Nov 22, 2000
Appl. No.:
09/717095
Inventors:
Aaron I. Vinik - Norfolk VA, US
Gary L. Pittenger - Virginia Beach VA, US
Lawrence Rosenberg - Montreal, CA
Jean T. S. Duguid - Quebec, CA
Gary L. Pittenger - Virginia Beach VA, US
Lawrence Rosenberg - Montreal, CA
Jean T. S. Duguid - Quebec, CA
Assignee:
McGill Unviersity
Eastern Virginia Medical School of the Medical College of Hampton Roads - Norfolk VA
Eastern Virginia Medical School of the Medical College of Hampton Roads - Norfolk VA
International Classification:
C12P 21/06
US Classification:
435 691, 435 71, 435 6, 4353201, 4352523, 435325, 536 231, 536 235, 536 241, 530350
Abstract:
Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display technique a cDNA clone expressed in cellophane wrapped but not in control pancreata was identified. Using this cDNA as a probe, a cDNA library was screened and a gene not previously described was identified and named INGAP.
High Level Of Expression Of Ingap In Bacterial And Euraryotic Cells
US Patent:
5804421, Sep 8, 1998
Filed:
Aug 12, 1997
Appl. No.:
8/909725
Inventors:
Aaron I. Vinik - Norfolk VA
Gary L. Pittenger - Virginia Beach VA
Scott W. Barlow - Norfolk VA
Gary L. Pittenger - Virginia Beach VA
Scott W. Barlow - Norfolk VA
Assignee:
Eastern Virginia Medical School of the Medical College fo Hampton Roads - Norfolk VA
International Classification:
C12N 1500
US Classification:
435 691
Abstract:
Removal of the nucleotide sequence encoding the signal peptide from the INGAP coding sequence allows cultured cells to express substantial amounts of INGAP activity. Previous attempts have provided only low yields of INGAP, possibly because the signal sequence of INGAP is toxic to the cells.
Ingap Protein Involved In Pancreatic Islet Neogenesis
US Patent:
RE39299, Sep 19, 2006
Filed:
Nov 13, 2000
Appl. No.:
09/709585
Inventors:
Aaron I. Vinik - Norfolk VA, US
Gary L. Pittenger - Virginia Beach VA, US
Lawrence Rosenberg - Montreal, CA
Jean T. S. Duguid - Quebec, CA
Gary L. Pittenger - Virginia Beach VA, US
Lawrence Rosenberg - Montreal, CA
Jean T. S. Duguid - Quebec, CA
Assignee:
Eastern Virginia Medical School of the Medical College of Hampton Roads - Norfolk VA
McGill University - Quebec
McGill University - Quebec
International Classification:
C07K 14/00
US Classification:
512 2, 530350, 530412, 435 691, 435 697, 514 12, 514 13, 514 14, 4241981
Abstract:
Cellophane wrapping (CW) of hamster pancreas induces proliferation of duct epithelial cells followed by endocrine cell differentiation and islet neogenesis. Using the mRNA differential display technique a cDNA clone expressed in cellophane wrapped but not in control pancreata was identified. Using this cDNA as a probe, a cDNA library was screened and a gene not previously described was identified and named INGAP.
Ingap Displacement Assays
US Patent:
6986994, Jan 17, 2006
Filed:
Jan 7, 2002
Appl. No.:
10/036418
Inventors:
Aaron I. Vinik - Norfolk VA, US
David A. Taylor-Fishwick - Norfolk VA, US
David A. Taylor-Fishwick - Norfolk VA, US
Assignee:
GMP Endotherapeutics, Inc. - Fort Lauderdale FL
International Classification:
G01N 33/53
US Classification:
435 71, 435 74, 435 75, 435 792, 435 793, 436 15, 436 43, 436514, 436543, 436544, 436545, 436546
Abstract:
An antibody is provided which specifically recognizes and binds to INGAP protein. The antibody is used in competitive binding assays for quantitation of INGAP in biological samples. The assay can be performed on a solid support or in a suspension.
Ingap Displacement Assays
US Patent:
7442774, Oct 28, 2008
Filed:
Oct 6, 2005
Appl. No.:
11/244524
Inventors:
Aaron I. Vinik - Norfolk VA, US
David A. Taylor-Fishwick - Norfolk VA, US
David A. Taylor-Fishwick - Norfolk VA, US
Assignee:
GMP Endotherapeutics, Inc. - Fort Lauderdale FL
International Classification:
G01N 33/53
US Classification:
5303871, 5303872, 5303873, 435 71, 435 72
Abstract:
An antibody is provided which specifically recognizes and binds to INGAP protein. The antibody is used in competitive binding assays for quantitation of INGAP in biological samples. The assay can be performed on a solid support or in a suspension.